Efficacy and safety of tofacitinib in patients with polymyalgia rheumatica: a phase 2 study

Ann Rheum Dis. 2023 May;82(5):722-724. doi: 10.1136/ard-2022-223562. Epub 2023 Jan 5.
No abstract available

Keywords: Glucocorticoids; Polymyalgia Rheumatica; Therapeutics.

Publication types

  • Clinical Trial, Phase II
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Giant Cell Arteritis*
  • Glucocorticoids
  • Humans
  • Piperidines / adverse effects
  • Polymyalgia Rheumatica* / drug therapy
  • Pyrimidines / adverse effects

Substances

  • tofacitinib
  • Piperidines
  • Pyrimidines
  • Glucocorticoids

Associated data

  • ClinicalTrials.gov/NCT04799262